Drug application
DARIFENACIN (DARIFENACIN HYDROBROMIDE)
Drugs@FDA ANDA 207302 · MACLEODS PHARMS
Key facts
| Drug name | DARIFENACIN |
|---|---|
| Active ingredients | DARIFENACIN HYDROBROMIDE |
| Application type | ANDA |
| Application number | 207302 |
| Company | MACLEODS PHARMS |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | EQ 7.5MG BASE |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Jul 28, 2017 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.